Volume 21, Issue 8 pp. 3530-3536
ORIGINAL ARTICLE

Use of quantum molecular resonance energy for managing postrhinoseptoplasty perilesional edema and ecchymosis

Tae Hwan Ahn MD, PhD

Tae Hwan Ahn MD, PhD

Fresh Facial Aesthetic Surgery and ENT Clinic, Seoul, Korea

Search for more papers by this author
Do Yeon Kim MS

Do Yeon Kim MS

BNV Biolab, Seoul, Korea

Search for more papers by this author
Hyoung-Moon Kim MD

Hyoung-Moon Kim MD

Maylin Clinic (Ilsan), Goyang, Korea

Search for more papers by this author
Wook Oh MD

Wook Oh MD

Maylin Clinic (Yeouido), Seoul, Korea

Search for more papers by this author
Sung Bin Cho MD, PhD

Corresponding Author

Sung Bin Cho MD, PhD

Yonsei Seran Dermatology and Laser Clinic, Seoul, Korea

Correspondence

Sung Bin Cho, Yonsei Seran Dermatology and Laser Clinic, 224 Siheung-daero, Seoul 08628, Korea.

Email: [email protected]

Search for more papers by this author
First published: 18 November 2021
Citations: 2

Abstract

Background

Quantum molecular resonance (QMR) technology employs nonionizing high-frequency waves ranging from 4 to 64 MHz to generate low-intensity quanta of energy that interacts with cellular components.

Aims

To evaluate the efficacy and safety of QMR treatment on postoperative perilesional edema and ecchymosis in patients with rhinoseptoplasty or revision rhinoseptoplasty.

Patients/Methods

In total, 30 patients were treated with QMR stimulation therapy (QMR group) once daily for 5 days, while another 30 patients were treated with conventional icepack application (control group). The duration of perilesional edema and ecchymosis were comparatively evaluated according to anatomic regions.

Results

In both groups, the longest duration of postoperative edema and ecchymosis was found on the left anterior cheek, followed by the right anterior cheek, left lower eyelid, right lower eyelid, and right and left upper eyelids. The mean duration of overall postoperative perilesional edema was significantly shorter in the QMR group (2.0 ± 0.8 days) than the control group (4.6 ± 2.0 days); the mean duration of overall ecchymosis was also markedly shorter in the QMR group (2.9 ± 1.5 days) than control group (7.5 ± 2.9 days). Patient satisfaction after postoperative QMR treatment was rated as 2.2 ± 0.8, whereas patient satisfaction in control group was rated as 1.6 ± 0.9.

Conclusion

Our clinical study demonstrated that postrhinoseptoplasty QMR treatment effectively reduces the duration of postoperative perilesional edema and ecchymosis without remarkable side effects. We suggest that QMR treatment can be considered as an alternative option for noninvasively managing postrhinoseptoplasty perilesional edema and ecchymosis.

CONFLICT OF INTEREST

None.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author, upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.